Subject: GCGX is adding a Medical Grade Nutraceutical's Division

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
GCGX Expands Reach Adding a Medical Grade Nutraceutical's Division Updates on Upcoming Conference Call for March 22nd
Hot Stock to WatchHot Stock to Watch

Company: Global Consortium, Inc. (Pink Sheets: GCGX)


Price: 0.027

Change (%): - 0.003 (10.00)

Volume: 836,323
GCGX Chart

Global Consortium, Inc., is adding a Medical Grade Nutraceutical's Division

COCONUT CREEK, Fla., March 14, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Global Consortium, Inc., (OTCPINK: GCGX) is expanding Infused Edibles with a new Nutraceuticals line.

The new line will consist of lotions, balms, ointments, liquids, pills, and powders.

The new division will be overseen by medical doctors and veterinarians of varying specialties, custom designing infused formulas not currently available. These proprietary formulas will be designed as a holistic approach to help treat a wide range of ailments in humans and animals.

Each new formula will be compounded and tested by a lab in California prior to being made available to the general public.

Some of the formulas will made available directly to the public, while others will be marketed to medical practices as "White Labeled" products that can be custom tailored to each doctors practice.

The first two specialty products are expected to be ready to hit the market by the end of June.

Continue Reading

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks